Rights Issue Details & Fund Utilization
Rights Issue Launched (May 27 – Jun 16, 2025): Issued 31 lakh equity shares at ₹325 each (face value ₹10 + premium ₹315), leading to a target raise of ₹100.75 cr.
Funds Raised So Far: ~₹85 cr successfully subscribed, with the remaining ₹15 cr expected by mid-July.
Investor Participation: Led by DS Group and existing backers like Kirin. Over 300 investors, including a new family office, have participated.
Purpose of Funds:
Working capital & vendor payments
General corporate expenses & compliance strengthening
🚨 Catalysts: What Triggered the Rights Issue
1. Heavy Discount & Financial Pressure
Rights price (₹325) was 55% lower than previous investment price (₹718), signaling tight liquidity.
FY24 metrics: Revenue fell 22% to ₹638.5 cr; losses surged 68% to ₹748.8 cr.
2. Operational & Regulatory Disruption
Failure to timely renew licenses after shifting from “Private Ltd” → “Ltd” status led to a 4–6 month halt in several states, wiping out ₹80 cr in inventory.
Supply chain and distribution suffered major downtime, causing sharp volume and revenue decline.
3. Andhra Pradesh Facility Shutdown
Bira’s largest production facility in Andhra Pradesh, contributing 25–30% of its total output, was shut down in March 2025 due to non-payment of excise dues.
The unit was fully vacated, and contracts terminated. Promoter personally intervened to retrieve stuck inventory.
Post-closure, production dropped from 22 lakh cases/month to just 10,000–20,000 cases/month (via Mysuru contract unit only).
4. Cost-Cutting & Realignment
Workforce halved from ~975 to ~500 employees.
Shifted to an asset-light model using third-party contract manufacturers (Mysuru, Nagpur), while shutting units like Tripti Brewery (Madhya Pradesh).
Manufacturing capacity cut by ~40%, projecting ₹600 cr in savings and improved margin outlook (targeting 66% gross margin by FY26).
🌱 Post-Issue Snapshot
Operational Revival: Delhi & UP markets restarting; UP factory ramp-up planned by 2026.
Regulatory Remediation: Licenses re-registered across states; compliance infrastructure being strengthened.
Restructuring in Progress: Leaner cost structure, emphasis on contract brewing, and pivot to core high-demand markets (Delhi, Maharashtra, UP, Andhra).
What to Monitor Going Forward
Focus Area
Key Metrics
Rights Issue Closure
Achieving full ₹100 cr by mid-July
UP Brewery Setup
Construction and ramp-up over H2 FY25
Q4 FY25 Performance
Any sign of revenue recovery and EBITDA improvement
Additional Fundraising
Possibility of debt deals (e.g., ₹500 cr via BlackRock)
License Stability
No recurrence of compliance delays
Summary Outlook
The rights issue is a strategic lifeline to stabilize operations and fund working capital post major disruptions.
Bira is now more asset-light and focused, with strict cost controls and contract manufacturing.
However, risks remain: completion of funding, UP facility delivery, no further regulatory setbacks, and early revenue recovery.
For existing and prospective investors, the completion of rights issue & performance of H2 FY25 will be critical catalysts for Bira’s unlisted market valuation.
Rights Issue Details & Fund Utilization
-
Rights Issue Launched (May 27 – Jun 16, 2025): Issued 31 lakh equity shares at ₹325 each (face value ₹10 + premium ₹315), leading to a target raise of ₹100.75 cr.
-
Funds Raised So Far: ~₹85 cr successfully subscribed, with the remaining ₹15 cr expected by mid-July.
-
Investor Participation: Led by DS Group and existing backers like Kirin. Over 300 investors, including a new family office, have participated.
Purpose of Funds:
-
Working capital & vendor payments
-
General corporate expenses & compliance strengthening
🚨 Catalysts: What Triggered the Rights Issue
1. Heavy Discount & Financial Pressure
-
Rights price (₹325) was 55% lower than previous investment price (₹718), signaling tight liquidity.
-
FY24 metrics: Revenue fell 22% to ₹638.5 cr; losses surged 68% to ₹748.8 cr.
2. Operational & Regulatory Disruption
-
Failure to timely renew licenses after shifting from “Private Ltd” → “Ltd” status led to a 4–6 month halt in several states, wiping out ₹80 cr in inventory.
-
Supply chain and distribution suffered major downtime, causing sharp volume and revenue decline.
3. Andhra Pradesh Facility Shutdown
-
Bira’s largest production facility in Andhra Pradesh, contributing 25–30% of its total output, was shut down in March 2025 due to non-payment of excise dues.
-
The unit was fully vacated, and contracts terminated. Promoter personally intervened to retrieve stuck inventory.
-
Post-closure, production dropped from 22 lakh cases/month to just 10,000–20,000 cases/month (via Mysuru contract unit only).
4. Cost-Cutting & Realignment
-
Workforce halved from ~975 to ~500 employees.
-
Shifted to an asset-light model using third-party contract manufacturers (Mysuru, Nagpur), while shutting units like Tripti Brewery (Madhya Pradesh).
-
Manufacturing capacity cut by ~40%, projecting ₹600 cr in savings and improved margin outlook (targeting 66% gross margin by FY26).
🌱 Post-Issue Snapshot
-
Operational Revival: Delhi & UP markets restarting; UP factory ramp-up planned by 2026.
-
Regulatory Remediation: Licenses re-registered across states; compliance infrastructure being strengthened.
-
Restructuring in Progress: Leaner cost structure, emphasis on contract brewing, and pivot to core high-demand markets (Delhi, Maharashtra, UP, Andhra).
What to Monitor Going Forward
| Focus Area |
Key Metrics |
r>
| Rights Issue Closure |
Achieving full ₹100 cr by mid-July |
| UP Brewery Setup |
Construction and ramp-up over H2 FY25 |
| Q4 FY25 Performance |
Any sign of revenue recovery and EBITDA improvement |
| Additional Fundraising |
Possibility of debt deals (e.g., ₹500 cr via BlackRock) |
| License Stability |
No recurrence of compliance delays |
Summary Outlook
-
The rights issue is a strategic lifeline to stabilize operations and fund working capital post major disruptions.
-
Bira is now more asset-light and focused, with strict cost controls and contract manufacturing.
-
However, risks remain: completion of funding, UP facility delivery, no further regulatory setbacks, and early revenue recovery.
-
For existing and prospective investors, the completion of rights issue & performance of H2 FY25 will be critical catalysts for Bira’s unlisted market valuation.
Disclaimer: This article is for informational purposes only and is not investment advice, nor an offer to buy or sell any security. Unlisted share prices are indicative. Please do your own research or consult a SEBI-registered advisor before investing.